PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model

BMB Reports

Volumn 48, Issue 7, 2015, Pages 407-412

  Hwang, Hyun Sook ^a,b   Park, In Young ^a,b   Kim, Dae Won ^b   Choi, Soo Young ^b   Jung, Young Ok ^c   Kim, Hyun Ah ^a,b  

^a Hallym University College of Medicine   (China)

^b Hallym University   (South Korea)

^c Kangnam Sacred Heart Hospital   (South Korea)

Author keywords

Chondrocyte; FK506 binding protein 12; Metalloproteinase; Osteoarthritis; Protein transduction domain

Indexed keywords

CARRAGEENAN; COLLAGENASE 3; FK 506 BINDING PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MERCAPTAMINE; MITOGEN ACTIVATED PROTEIN KINASE; PEP-1 PEPTIDE; PEPTIDE;

ANALOGS AND DERIVATIVES; ANIMAL; ARTHRITIS; ARTICULAR CARTILAGE; CELL CULTURE; CHEMICALLY INDUCED; CHONDROCYTE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; EDEMA; ENZYMOLOGY; GENETIC TRANSDUCTION; HUMAN; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ARTHRITIS; CARRAGEENAN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; CYSTEAMINE; DISEASE MODELS, ANIMAL; EDEMA; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 13; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PEPTIDES; RECOMBINANT FUSION PROTEINS; TACROLIMUS BINDING PROTEIN 1A; TRANSDUCTION, GENETIC;

EID: 84938574640     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.7.050     Document Type: Article

References (26)

1. Goldring MB 2000.The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43, 1916-1926
2. Goldring MB and Goldring SR 2007.Osteoarthritis. J Cell Physiol 213, 626-634
3. Goldring MB and Berenbaum F (2004) The regulation of chondrocyte function by proinflammatory mediators:prostaglandins and nitric oxide. Clin Orthop Relat Res 427 Suppl, S37-S46
4. Goldring SR and Goldring MB (2004) The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 427 Suppl, S27-S36
5. Venkatesan N, Barre L, Benani A et al 2004.Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repair. Proc Natl Acad Sci U S A 101, 18087-18092
6. Kim HA, Kim DW, Park J, and Choi SY (2006) Transduction of Cu, Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into human chondrocytes. Arthritis Res Ther 8, R96
7. Schiene-Fischer C and Yu C 2001.Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases. FEBS Lett 495, 1-6
8. Kim DW, Lee SH, Ku SK et al 2013.Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse model. BMB Rep 46, 124-129
9. Kim SY, Sohn EJ, Kim DW et al 2013.Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J Invest Dermatol 131, 1477-1485
10. Yang S, Kim J, Ryu JH et al 2010.Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 16, 687-693
11. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, and Brinckerhoff CE 2000.Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43, 801-811
12. Fujii T, Onohara N, Maruyama Y et al 2005.Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. J Biol Chem 280, 23041-23047
13. Kabouridis PS, Hasan M, Newson J, Gilroy DW, and Lawrence T 2002.Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha. J Immunol 169, 2587-2593
14. Klein D, Ribeiro MM, Mendoza V et al 2004.Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets. Biochem Biophys Res Commun 323, 473-478
15. Lee H, Ryu J, Kim KA et al 2004.Transduction of yeast cytosine deaminase mediated by HIV-1 Tat basic domain into tumor cells induces chemosensitivity to 5-fluorocytosine. Exp Mol Med 36, 43-51
16. Ozaki D, Sudo K, Asoh S, Yamagata K, Ito H, and Ohta S 2004.Transduction of anti-apoptotic proteins into chondrocytes in cartilage slice culture. Biochem Biophys Res Commun 313, 522-527
17. Katsura K, Takahashi K, Asoh S et al 2008.Combination therapy with transductive anti-death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat. J Neurochem 106, 258-270
18. van den Berg A and Dowdy SF 2011.Protein transduction domain delivery of therapeutic macromolecules. Curr Opin Biotechnol 22, 888-893
19. Morris MC, Depollier J, Mery J, Heitz F, and Divita G (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19, 1173-1176.
20. Gros E, Deshayes S, Morris MC et al 2006.A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim Biophys Acta 1758, 384-393
21. Kang CB, Hong Y, Dhe-Paganon S, and Yoon HS 2008.FKBP family proteins: immunophilins with versatile biological functions. Neurosignals 16, 318-325
22. Qi Y, Ogunbunmi EM, Freund EA, Timerman AP, and Fleischer S 1998.FK-binding protein is associated with the ryanodine receptor of skeletal muscle in vertebrate animals. J Biol Chem 273, 34813-34819
23. Cameron AM, Steiner JP, Roskams AJ, Ali SM, Ronnett GV, and Snyder SH 1995.Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell 83, 463-472
24. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, and Snyder SH 1995.Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci U S A 92, 1784-1788
25. Lee NH, Jung YS, Lee HY et al 2014.Mouse neutrophils express functional umami taste receptor T1R1/T1R3. BMB Rep 47, 649-654
26. Li J, Jiang K, Qiu X et al (2014) Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer BMB Rep 47, 33-38